Alifano Marco, Parri Sergio N Forti, Arab Walid Abu, Bonfanti Barbara, Lacava Nicola, Porrello Calogero, Boaron Maurizio
Thoracic Surgery Department, Maggiore-Bellaria Hospital, Bologna, Italy.
Surg Today. 2008;38(4):300-4. doi: 10.1007/s00595-007-3626-1. Epub 2008 Mar 27.
To evaluate the status of limited upper sternal split in general thoracic surgery.
We reviewed the clinical files of 100 consecutive patients operated on through limited upper sternotomy at a hospital in Italy during the 10 years between January 1995 and December 2004.
Thymus surgery represented the main indication for this approach (n = 51): for myasthenia without thymoma in 28 patients, for thymus neoplasms with or without myasthenia in 22, and for intrathymic parathyroid adenoma in 1. Thyroid surgery constituted the second main indication for upper sternal split (n = 32) for benign retrosternal goiter in 18 patients, for mediastinal nodal metastasis of thyroid cancer in 11, and for malignant retrosternal goiter in 3. The remaining indications were as follows: to assess residual disease following chemotherapy for Hodgkin's disease in 7 patients and for non-Hodgkin lymphoma in 1; for tracheal surgery in 7; and for excision of nodal mediastinal metastasis of non-thyroid cancer in 2. All operations were completed through the upper sternal split. There was no surgical mortality but complications developed in eight patients.
The upper sternal split provides a satisfactory access to perform a surgical procedure in the superior mediastinum in most diseases. The procedure is safe and involves minimal surgical trauma.
评估上半胸骨劈开术在普通胸外科中的应用情况。
我们回顾了1995年1月至2004年12月期间,意大利一家医院连续100例接受上半胸骨切开术患者的临床资料。
胸腺手术是该手术方式的主要适应证(n = 51):28例无胸腺瘤的重症肌无力患者,22例有或无重症肌无力的胸腺肿瘤患者,以及1例胸腺内甲状旁腺腺瘤患者。甲状腺手术是上半胸骨劈开术的第二大主要适应证(n = 32):18例良性胸骨后甲状腺肿患者,11例甲状腺癌纵隔淋巴结转移患者,以及3例恶性胸骨后甲状腺肿患者。其余适应证如下:7例霍奇金病化疗后评估残留病灶,1例非霍奇金淋巴瘤化疗后评估残留病灶;7例气管手术;2例非甲状腺癌纵隔淋巴结转移切除术。所有手术均通过上半胸骨劈开术完成。无手术死亡病例,但8例患者出现了并发症。
上半胸骨劈开术为大多数疾病的上纵隔手术提供了满意的手术入路。该手术安全,手术创伤极小。